Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Gynecol Oncol. 2011 Sep;122(3):604-7. doi: 10.1016/j.ygyno.2011.05.024. Epub 2011 Jun 11.
Minimally invasive surgery offers advantages for management of obese patients, but technical difficulty often deters its utilization. Compared to laparotomy, robotic surgery should allow comparable staging and improved surgical outcomes. Therefore, we evaluated outcomes in robotic and laparotomy cohorts of obese women with endometrial cancer at our institution.
Retrospective robotic and laparotomy cohorts of obese women (BMI ≥ 30 kg/m(2)) undergoing surgical management of primary endometrial cancer from March 2006 to March 2009 were formulated utilizing a computerized database. Patient demographics, operative statistics, peri-operative complications, and pathologic details were collected in an intent to treat analysis. Chi-square or Fisher's exact test and t-test were used for statistical analysis.
73 women underwent robotic surgical management, 11% converted to laparotomy. Mean BMI (39.8 vs. 41.9, p=0.152), number of co-morbidities (2.49 vs. 2.62, p=0.690), number of previous surgeries (0.97 vs. 0.94, p=0.841), and lymphadenectomies performed (65.8% vs. 56.7%, p=0.227) were similar between cohorts. Total lymph nodes obtained were not statistically different between cohorts (8.01 vs. 7.24, p=0.505). Total operative time and room time was significantly longer for robotic surgery; however, estimated blood loss, the percentage of patients receiving transfusion, hospital length of stay, wound complications (4.1% vs. 20.2%, p=0.002) and other complications (9.6% vs. 29.8%, p=0.001) were improved for the robotic cohort.
Robotic management of obese women with endometrial cancer yields acceptable staging results and improved surgical outcomes. Although operating time is longer, hospital time is shorter. Robotic surgery may be an ideal approach for these patients.
微创手术为肥胖患者的治疗提供了优势,但技术难度常常阻碍了其应用。与开腹手术相比,机器人手术应该能够进行类似的分期,并改善手术结果。因此,我们评估了我们机构中肥胖的子宫内膜癌女性患者的机器人手术和开腹手术队列的结果。
利用计算机数据库,制定了 2006 年 3 月至 2009 年 3 月期间接受肥胖(BMI≥30kg/m2)原发性子宫内膜癌手术治疗的肥胖女性患者的机器人和开腹手术回顾性队列。在意向治疗分析中收集了患者的人口统计学、手术统计学、围手术期并发症和病理细节。使用卡方或 Fisher 精确检验和 t 检验进行统计分析。
73 名女性接受了机器人手术治疗,其中 11%转为开腹手术。两组患者的平均 BMI(39.8 与 41.9,p=0.152)、合并症数量(2.49 与 2.62,p=0.690)、手术次数(0.97 与 0.94,p=0.841)和进行的淋巴结清扫术(65.8%与 56.7%,p=0.227)相似。两组患者获得的总淋巴结数无统计学差异(8.01 与 7.24,p=0.505)。机器人手术的总手术时间和手术室时间明显更长;然而,机器人手术组的估计出血量、输血患者比例、住院时间、伤口并发症(4.1%与 20.2%,p=0.002)和其他并发症(9.6%与 29.8%,p=0.001)的发生率均有所改善。
机器人手术治疗肥胖的子宫内膜癌患者可获得可接受的分期结果和改善的手术结果。尽管手术时间较长,但住院时间较短。机器人手术可能是这些患者的理想方法。